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Abstract Headache associated with moyamoya disease
(HAMD) is common in moyamoya disease. However, the
characteristics and classification of HAMD are largely
unknown. We present a case of a 39-year-old woman with
HAMD. To characterize and classify the features of this
syndrome, the patient was asked to complete a 4-month
diagnostic headache diary. There was a total of 15 ictal
days. All episodes were without aura. The headache was
more commonly pressing (10/15), mild to moderate in
severity (14/15), unchanged by physical activity (11/15),
and associated with photophobia (10/15). The International
Headache Society Classification was utilized to determine
that eight episodes met criteria for probable migraine
without aura, while seven episodes met criteria for proba-
ble frequent episodic tension-type headache. We identified
four other case reports of HAMD with partial descriptions
of the characteristics. When combined with our patient, the
median age was 34 years old (range 6–49, SD 16). Four
were female, while the patient with cluster headache was
male. The median time from headache onset to diagnosis
with moyamoya disease was 9.5 months (range 0–192, SD
88.0). Headaches were described as migraine with aura in
two of five cases, hemiplegic migraine in one of five, and
cluster headache in one of five. The highest intensity was
described as severe in three of three cases, in which
headache intensity was reported. Meanwhile, nausea,
vomiting, and photophobia were present in two of three
cases, where these features were reported, while nausea
without vomiting was seen in one of three cases. In all five
cases, patients had other neurological symptoms, such as
paresis, seizures, visual disturbances, dysarthria, allodynia,
ptosis, and unilateral restless leg syndrome. In conclusion,
HAMD can present as migraine without aura. It can be the
first presenting symptom of moyamoya disease. The
headache features are not diagnostic; hence, early neuro-
vascular imaging should be considered in patients with new
onset, refractory migraine-like headache, especially in the
setting of other neurological symptoms to exclude under-
lying moyamoya disease. Further reports using headache
diaries are needed to better characterize HAMD as well as
to determine whether headache with tension-type features
is also part of this condition.
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Introduction
Moyamoya disease is an uncommon illness of cerebral
vasculature that is identified by stenosis of the distal
internal carotid arteries and their branches. Dilation of
small collateral vessels in an attempt to compensate for the
decreased blood flow in the anterior circulation produces
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the characteristic ‘‘puff of smoke’’ appearance on angiog-
raphy [1]. There are primary forms of moyamoya (i.e.
moyamoya disease) and forms secondary to radiation to
head and neck, Down’s syndrome, sickle cell disease,
neurofibromatosis type I, severe intracranial atherosclero-
sis, fibromuscular dysplasia, hyperthyroidism, bacterial
meningitis, combined cigarette smoking and oral contra-
ceptive use, Sjogren syndrome and cocaine abuse (i.e.
moyamoya syndrome) [1]. In this paper, we will focus on
moyamoya disease. Clinically, this illness may result in
various combinations of ischemic and hemorrhagic stroke,
transient focal neurologic deficits, and seizures. Headache
associated with moyamoya disease (HAMD) is common in
moyamoya disease and persists in 63% of patients even
after successful surgical revascularization [2]. In some
instances, headache may be the presenting symptom of
moyamoya disease [2]. However, there are only a few
reports of HAMD with a description of headache quality
and associated symptoms. We asked a 39-year-old woman
with HAMD to keep a headache diary [3] to better char-
acterize her headache. To our knowledge, this is the first
time a headache diary was used to characterize HAMD in a
case report. We also conducted a literature review and were
able to identify three cases of HAMD with description of
headache quality and associated symptoms [4–6]. We
combined our case with those from the literature review to
characterize the features of HAMD. We also discuss the
possible pathophysiology of HAMD.
Patient history
A 39-year-old, right handed, obese, Hispanic woman pre-
sented to the neurology clinic at the Montefiore Medical
Center with a complaint of a hissing, buzzing noise in her
ear for the past 5 months. The noise was daily, continuous,
and more pronounced on the left. The patient initially did
not report headache, neurological deficits, ear pain, fevers,
or rash. She had a history of poorly controlled type 2
diabetes mellitus, hyperlipidemia, hypertension, and
asthma. She had no history of neck trauma, chiropractor
visits, hyperextension (like in yoga class or in hair salons
when they wash hair), nor any motor vehicle accident with
whiplash injury. Her medications included aspirin, zolpi-
dem, metformin, fosinopril, atorvastatin, and pioglitazone.
Her family history was significant for ‘‘minor strokes’’ in
her father and headaches in her brother that could not be
further characterized. She was referred to otolaryngology
for tinnitus. There she had a normal examination. This led
to a referral to neurology. On physical examination, she
had bilateral carotid bruits. Otherwise, her neurological
examination was normal. A CT scan of the head did not
reveal any abnormalities. In addition, she had a CT
angiogram of the head and neck, which revealed an
occlusion of both internal carotid arteries and reconstitu-
tion of the distal middle cerebral arteries via collaterals.
The left internal carotid artery (ICA) smoothly tapered just
distal to the common carotid bifurcation, while the right
ICA tapered more distally. A conventional catheter cere-
bral angiogram confirmed the occlusion of the left ICA
within the neck and the occlusion of the right ICA just
above the ophthalmic artery origin. Collateral blood supply
to the anterior circulation from the external carotid arteries
as well as from the posterior circulation was demonstrated.
Furthermore, there were dilated, tortuous lenticulostriate,
and thalamostriate arteries with a typical, ‘‘puff of smoke’’
appearance (Fig. 1).
Evaluation for contributing hypercoagulable states
included a C-reactive protein, a vasculitis work-up (ANA,
ANCA, RF, anti-Ro, and anti-La), an RPR and a sickle cell
screen. These tests were unrevealing. The patient had no
history of cocaine or illicit drug use. She did not have
Fig. 1 Conventional cerebral
angiogram of our patient.
a The LICA is occluded just
after the bifurcation of the
LCCA, b the RICA narrows and
becomes occluded intracranially
(white, dotted lines). Distally,
the dilated lenticulostriate
arteries create a ‘‘puff of
smoke’’ appearance. LICA left
internal carotid artery, LCCA
left common carotid artery,
RICA right internal carotid
artery
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Down’s syndrome. There was no evidence of severe ath-
erosclerosis, fibromuscular dysplasia, neurofibromatosis, or
craniopharyngioma. On angiography, there was no evi-
dence of dissection. In contrast, the dilated collaterals were
present bilaterally and both of the ICAs were occluded.
The intracranial location of the right ICA occlusion is
consistent with moyamoya disease. The left ICA tapered
just past the bifurcation of the common carotid, which is a
finding that may be seen with atherosclerosis [7, 8] or
moyamoya disease. There was no other evidence of ath-
erosclerotic disease in the remaining cerebral vasculature.
Based on these findings, we diagnosed the patient with
moyamoya disease.
At 2 months follow-up, the patient complained of epi-
sodic headaches that were bilateral, frontal, pressure-like,
moderate to severe in intensity, lasting for 3 h, associated
with photophobia, allodynia, and light headedness. Fol-
lowing the consultation, the patient was instructed to
complete a 4-month diagnostic headache diary. She had a
headache on 15 out of 121 days (12% ictal, 88% headache
free). Her headaches were treated with naproxen and
acetaminophen. The patient is being followed at the neu-
rology clinic. She is currently not scheduled for any bypass
surgery or revascularization.
Results and literature review
We used a diagnostic headache diary and the second edi-
tion of the International Classification of Headache Dis-
orders (ICHD-II) from the International Headache Society
(IHS) to classify our patient’s headache [9]. The headache
features derived from the diary are presented in Table 1.
The ICHD-II [9] of our patient’s headache is presented in
Table 2. Prior literature describes HAMD as migrainous in
quality and refractory to both prophylactic and abortive
medical therapies [2]. Recently, cluster headache was
reported in moyamoya disease [10]. Surprisingly, using the
ICHD-II, we found that our patient’s HAMD was not
always migrainous. Rather, it was an almost even mixture
of probable migraine without aura and tension-type head-
ache. Uncharacteristically, our patient responded to abor-
tive agents and did not require prophylactic therapy.
In addition to our case, we identified four [4–6, 10] other
case reports with a detailed description of the headache
pattern in moyamoya for a total of five cases. The median
age of our five patients with HAMD was 34 years old
(range 6–49, SD 16.0). Four were female while the patient
with cluster headache was male. The median time from
headache onset to diagnosis with moyamoya disease was
9.5 months (range 0–192, SD 88.0). Headaches were
described as migraine with aura in two of five cases,
hemiplegic migraine in one of five, and cluster headache in
one of five. The highest intensity was described as severe in
three of three cases, in which headache intensity was
reported. Meanwhile, nausea, vomiting and photophobia
Table 1 Percentages of headache characteristics in a patient with
moyamoya disease during 4-month period (n = 15)






































Table 2 IHS Classification of Headache Types in our patient with
moyamoya disease
IHS Classification ICHD-II (n = 15) n (%)
Probable migraine without aura 1.6.1. 8 (53)
Probable frequent episodic tension-type headache 2.4.2. 7 (47)
J Headache Pain (2010) 11:79–82 81
123
were present in two of three cases where these features
were reported, while nausea without vomiting was seen in
one of three cases. In all five cases, patients had other
neurological symptoms, such as paresis, seizures, visual
disturbances, dysarthria, allodynia, ptosis, and unilateral
restless leg syndrome.
Discussion
The mechanism of HAMD is uncertain and may be multi-
factorial. Moyamoya disease results in narrowing and ulti-
mately occlusion of intracranial vasculature. It is possible
that HAMD is also caused by this blood vessel pathology
[2]. The role of cerebral artery nociceptors in generation of
HAMD is supported by studies where stretch of intracere-
bral vasculature produced nausea and referred pain in
regions typically involved in migraine attacks [11, 12].
Furthermore, cerebral aneurysms and arteriovenous
malformations are frequently found in moyamoya disease
(incidence 11–14.2%) and may account for the headache in
at least a subset of patients by two possible mechanisms [2,
13, 14]. One mechanism may be the stimulation of tri-
geminal nociceptors due to stretch caused by the enlarging
aneurysm [15]. The second mechanism may be a sentinel
aneurysmal bleed into the subarachnoid space, which has
previously been associated with the generation of headache
with pulsating quality accompanied by photophobia, nau-
sea, and vomiting [15].
Neurogenic inflammation seen in moyamoya disease
may also play a role in generating HAMD. The inflam-
mation results in stretch of perivascular nociceptors
innervating intracranial vasculature and leads to a release
of pro-nociceptive mediators. These include substance P
and calcitonin gene-related peptide from trigeminal nerve
endings. The release leads to activation of nociceptors
producing both generation and maintenance of the head-
ache [11, 16].
Finally, the progressive intracranial stenosis seen in
moyamoya disease leads to cerebral hypoperfusion and
induces an intracranial oligemic state. This hypoperfusion
has been described as an etiology of headache as well [5].
Indeed, some patients experience an improvement in
HAMD after surgical intervention intended to improve
cerebral blood flow [2, 17]. This notion is further supported
by the fact that hyperventilation, which is known to cause
cerebral vasoconstriction and thus hypoperfusion, has been
associated with both headache generation and transient
ischemic attacks in moyamoya disease [2].
In conclusion, HAMD can present as migraine without
aura. It can be the first presenting symptom of moyamoya
disease. The headache features are not diagnostic, hence
early neurovascular imaging should be considered in
patients with new onset, refractory migraine-like headache,
especially in the setting of other neurological symptoms to
exclude underlying moyamoya disease. Further reports
using headache diaries are needed to better characterize
HAMD as well as to determine if headache with tension-
type features is also part of this condition.
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